The Covid-19 vaccine maker announced the distribution deal Tuesday with Adium Pharma SA to market the shots in 18 countries in the region including Brazil and Mexico
BioNTech SE and Moderna Inc. are working to adapt their Covid-19 vaccines to address the omicron variant, with the German partner of Pfizer Inc. saying it could have a new version ready within 100 days if necessary.
“Los estudios mostraron que una dosis extra de estas vacunas aumentaba la capacidad de producir anticuerpos contra el virus que causa el Covid-19 en pacientes con trasplante de órganos con sistemas inmunitarios debilitados”, dijo la EMA.
